annual meeting program - American Society of Clinical Oncology

11:30 AM - 12:45 PM
EDUCATION SESSIONS
Evaluating the Evidence and Marketing of Pharmacogenomic Tests
Location: E353
CME credit: 1.25
Track(s): Cancer Genetics; Developmental Therapeutics; Pediatric Oncology
Howard L. McLeod, PharmD—Chair
University of North Carolina at Chapel Hill
Overview of Pharmacogenomics: History, Development, and Role in FDA Labeling
Matthew P. Goetz, MD
Mayo Clinic
CYP2D6 Testing and Tamoxifen
Michael L. Maitland, MD, PhD
The University of Chicago
Clinical Cases in Pharmacogenomics
Lessons Learned from Clinical Trials in Gastrointestinal Stromal Tumor
Location: S406 (Vista Room)
CME credit: 1.25
Track(s): Sarcoma
Jean-Yves Blay, MD, PhD—Chair
University Claude Bernard
Combination Therapy with Established and Novel Targeted Agents to Improve Outcomes in
Patients with Advanced GIST
Ronald P. DeMatteo, MD
Memorial Sloan-Kettering Cancer Center
The Role of Adjuvant Imatinib after Resection of Localized Primary GIST: An Update on the
Z9001 Trial—Optimal Duration of Therapy
Michael C. Heinrich, MD
Oregon Health & Science University
Dosing the Unusual Patient with Non-exon 9/11 GIST
Survivorship in Lymphoma
Location: E354a
CME credit: 1.25
Track(s): Lymphoma and Plasma Cell Disorders; Patient and Survivor Care
David J. Straus, MD—Chair
Memorial Sloan-Kettering Cancer Center
Long-term Toxicities of Lymphoma Therapy
Rebecca L. Elstrom, MD
Weill Cornell Medical College
Imaging in Lymphoma Patients: Who, When, How, and How Long?
Jennifer Mills, MSW, MPH
New York University School of Social Work
Psychosocial Issues of Lymphoma Survivors: Cured but Not Healed?
Sunday, June 6, 2010
243
SUNDAY